Back to Directory Anne Coletti Email acoletti@fhi360.org Phone (919) 627-6445 Institution FHI 360 Title Clinical Research Manager Address FHI 360 359 Blackwell St. Suite 200 Durham, NC 27701 Request an Update Affiliated Studies IMPAACT 2053: Long-Acting Injectable Cabotegravir as Postnatal Prophylaxis During Breastfeeding: Safety, Tolerability, and Model Development for Implementation DAIDS Number 39282 Research Area Therapeutics Study Status In Development IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants DAIDS Number TBD Research Area Therapeutics Study Status In Development IMPAACT 2042: Tatelo Plus DAIDS Number 39076 Research Area Cure and Immunotherapy Study Status Closed to Accrual Show All
IMPAACT 2053: Long-Acting Injectable Cabotegravir as Postnatal Prophylaxis During Breastfeeding: Safety, Tolerability, and Model Development for Implementation DAIDS Number 39282 Research Area Therapeutics Study Status In Development
IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development
IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants DAIDS Number TBD Research Area Therapeutics Study Status In Development
IMPAACT 2042: Tatelo Plus DAIDS Number 39076 Research Area Cure and Immunotherapy Study Status Closed to Accrual